Cerebrovascular risk factors, vascular disease, and neuropsychological outcomes in adults with major depression.

PubWeight™: 1.22‹?› | Rank: Top 10%

🔗 View Article (PMC 3595570)

Published in Psychosom Med on July 18, 2007

Authors

Patrick J Smith1, James A Blumenthal, Michael A Babyak, Benson M Hoffman, P Murali Doraiswamy, Robert Waugh, Alan Hinderliter, Andrew Sherwood

Author Affiliations

1: Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA. Smith562@mc.duke.edu

Articles citing this

Aerobic exercise and neurocognitive performance: a meta-analytic review of randomized controlled trials. Psychosom Med (2010) 3.57

Relations of arterial stiffness and endothelial function to brain aging in the community. Neurology (2013) 1.60

Carotid atherosclerosis and 10-year changes in cognitive function. Atherosclerosis (2012) 1.02

Executive function and depression as independent risk factors for postoperative delirium. Anesthesiology (2009) 1.02

Adverse impact of mood on flow-mediated dilation. Psychosom Med (2010) 0.95

The impact of vascular burden on late-life depression. Brain Res Rev (2009) 0.94

Intima-media thickness and age of first depressive episode. Biol Psychol (2008) 0.91

Neurocognitive changes after lung transplantation. Ann Am Thorac Soc (2014) 0.91

Vascular growth factors in neuropsychiatry. Cell Mol Life Sci (2013) 0.86

Delirium affects length of hospital stay after lung transplantation. J Crit Care (2014) 0.85

Associations between stroke risk and cognition in normal aging and Alzheimer's disease with and without depression. Int J Geriatr Psychiatry (2010) 0.84

Can lifestyle modification improve neurocognition? Rationale and design of the ENLIGHTEN clinical trial. Contemp Clin Trials (2012) 0.80

Association of vascular health and neurocognitive performance in overweight adults with high blood pressure. J Clin Exp Neuropsychol (2011) 0.79

The role of carotid intima-media thickness in predicting longitudinal cognitive function in an older adult cohort. Cerebrovasc Dis (2014) 0.79

Cerebrovascular risk factors and cerebral hyperintensities among middle-aged and older adults with major depression. Am J Geriatr Psychiatry (2010) 0.78

Executive functions in elderly men. Age (Dordr) (2011) 0.78

Endothelial function, folate pharmacogenomics, and neurocognition in psychotic disorders. Schizophr Res (2015) 0.77

Cardiovascular risk assessment in patients with a severe mental illness: a systematic review and meta-analysis. BMC Psychiatry (2016) 0.77

Vascular burden and cognitive functioning in depressed older adults. Am J Geriatr Psychiatry (2012) 0.77

Association between Carotid Artery Stenosis and Cognitive Impairment in Stroke Patients: A Cross-Sectional Study. PLoS One (2016) 0.76

Cognitive performance in older elderly men with late-life depression and cardiovascular comorbidities: symptomatological correlation. Ann Gen Psychiatry (2013) 0.75

Depressive Symptoms and Risk of Postoperative Delirium. Am J Geriatr Psychiatry (2016) 0.75

Articles cited by this

National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity. Arch Gen Psychiatry (1981) 18.92

Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet (1992) 11.50

Probability of stroke: a risk profile from the Framingham Study. Stroke (1991) 10.14

A structured interview guide for the Hamilton Depression Rating Scale. Arch Gen Psychiatry (1988) 8.53

'Vascular depression' hypothesis. Arch Gen Psychiatry (1997) 6.59

Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke (1994) 5.83

Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology (2001) 4.78

Depression: perspectives from affective neuroscience. Annu Rev Psychol (2002) 3.72

Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study. Arch Gen Psychiatry (2006) 3.61

Documentation and evaluation of cognitive impairment in elderly primary care patients. Ann Intern Med (1995) 3.37

Cognitive deficits in depression: possible implications for functional neuropathology. Br J Psychiatry (2001) 3.07

White matter lesions impair frontal lobe function regardless of their location. Neurology (2004) 2.77

Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol Aging (2000) 2.77

Frontal-subcortical circuits and neuropsychiatric disorders. J Neuropsychiatry Clin Neurosci (1994) 2.59

Low cholesterol concentrations and severe depressive symptoms in elderly people. BMJ (1994) 2.51

Framingham stroke risk profile and lowered cognitive performance. Stroke (2004) 2.46

Association of low serum total cholesterol with major depression and suicide. Br J Psychiatry (1999) 2.44

Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol (2002) 2.41

Incidence and occurrence of total (first-ever and recurrent) stroke. Stroke (1999) 2.39

Symptoms of depression as a prospective risk factor for stroke. Psychosom Med (2000) 2.32

Cognitive function in late life depression: relationships to depression severity, cerebrovascular risk factors and processing speed. Biol Psychiatry (2006) 1.92

NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study. Diabetes Care (1997) 1.89

Attention and executive functions in remitted major depression patients. J Affect Disord (2005) 1.84

Blood pressure, cognitive functions, and prevention of dementias in older patients with hypertension. Arch Intern Med (2001) 1.77

Neurocognitive impairment in drug-free patients with major depressive disorder. Br J Psychiatry (2003) 1.63

Carotid intima-media thickness, plaques, and Framingham risk score as independent determinants of stroke risk. Stroke (2005) 1.52

Relationship between arterial stiffness and cognitive function in elderly subjects with complaints of memory loss. Stroke (2005) 1.51

Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J Am Coll Cardiol (1994) 1.51

Cerebrovascular disease and depression symptoms in the cardiovascular health study. Stroke (1999) 1.50

Ultrasound measurement of wall thickness in the carotid artery: fundamental principles and description of a computerized analysing system. Clin Physiol (1991) 1.50

Impaired endothelial function in coronary heart disease patients with depressive symptomatology. J Am Coll Cardiol (2005) 1.47

Plasma HDL levels highly correlate with cognitive function in exceptional longevity. J Gerontol A Biol Sci Med Sci (2002) 1.43

Depression and vascular disease: what is the relationship? J Affect Disord (2004) 1.43

Cardiovascular disease and cognitive performance in middle-aged and elderly men. Atherosclerosis (2006) 1.40

Serum cholesterol and cognitive performance in the Framingham Heart Study. Psychosom Med (2005) 1.34

Dementia and neurodevelopmental predisposition: cognitive dysfunction in presymptomatic subjects precedes dementia by decades in frontotemporal dementia. Ann Neurol (2001) 1.34

Is the relation of systolic blood pressure to risk of cardiovascular disease continuous and graded, or are there critical values? Hypertension (2003) 1.33

White-matter integrity predicts stroop performance in patients with geriatric depression. Biol Psychiatry (2006) 1.32

Reduced neuropsychological test performance in asymptomatic carotid stenosis: The Tromsø Study. Neurology (2004) 1.32

Neuropsychological deficits among patients with late-onset minor and major depression. Arch Clin Neuropsychol (2003) 1.30

Cognitive function in depression: a distinct pattern of frontal impairment in melancholia? Psychol Med (1999) 1.20

Ultrasonographic assessment of carotid wall characteristics and cognitive functions in a community sample of 59- to 71-year-olds. The EVA Study Group. Stroke (1996) 1.15

Lifetime history of depression and carotid atherosclerosis in middle-aged women. Arch Gen Psychiatry (2003) 1.14

Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: relationship with immune-inflammatory markers. Acta Psychiatr Scand (1997) 1.14

The Ruff 2 and 7 Selective Attention Test: a neuropsychological application. Percept Mot Skills (1992) 1.13

Neuropsychological test profiles in schizophrenia and non-psychotic depression. Acta Psychiatr Scand (2006) 1.12

Cognitive function predicts first-time stroke and heart disease. Neurology (2005) 1.08

Blood vessel function and cognition in elderly patients with atherosclerosis. Stroke (2004) 1.05

Mood and neuropsychological function in depression: the role of corticosteroids and serotonin. Psychol Med (1998) 1.04

Serum cholesterol and intellectual performance. Psychosom Med (1997) 1.02

Depressive symptoms and carotid artery intima-media thickness in young adults: the Cardiovascular Risk in Young Finns Study. Psychosom Med (2005) 1.01

Longitudinal support for the relationship between vascular risk factors and late-life depressive symptoms. Am J Geriatr Psychiatry (2004) 1.00

Impaired divided attention predicts delayed response and risk to relapse in subjects with depressive disorders. Psychol Med (2004) 0.98

Hippocampal changes and white matter lesions in early-onset depression. Biol Psychiatry (2004) 0.90

Neuropsychiatric significance of subcortical hyperintensity. J Neuropsychiatry Clin Neurosci (2001) 0.90

Cerebrovascular risk factors, activity limitations, and depressed mood in African American older adults. Psychol Aging (2006) 0.84

Low serum cholesterol and depression. BMJ (1994) 0.77

Low serum cholesterol and serotonin metabolism. Risk of depression is higher in elderly patients with lowest serum cholesterol values. BMJ (1996) 0.77

Low serum cholesterol is not associated with depression in the elderly: data from an Australian community study. Aust N Z J Med (1994) 0.76

Articles by these authors

Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA (2011) 6.92

Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA (2009) 6.36

The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. J Am Coll Cardiol (2005) 5.33

Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation (2008) 5.15

Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med (2007) 4.49

Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet (2003) 4.21

Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med (2004) 3.94

Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study. Lancet Neurol (2012) 3.66

Aerobic exercise and neurocognitive performance: a meta-analytic review of randomized controlled trials. Psychosom Med (2010) 3.57

Effects of exercise training on depressive symptoms in patients with chronic heart failure: the HF-ACTION randomized trial. JAMA (2012) 3.46

Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry (2005) 3.41

Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale. Am Heart J (2007) 3.34

Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease: results from the UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy) study. J Am Coll Cardiol (2012) 3.19

Pulmonary hypertension in patients with sickle cell disease: a longitudinal study. Br J Haematol (2006) 3.02

Treatment course with antidepressant therapy in late-life depression. Am J Psychiatry (2012) 2.94

Depression as a risk factor for mortality after acute myocardial infarction. Am J Cardiol (2003) 2.87

Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA (2009) 2.83

Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease. Arch Neurol (2011) 2.81

Polygenic risk, rapid childhood growth, and the development of obesity: evidence from a 4-decade longitudinal study. Arch Pediatr Adolesc Med (2012) 2.70

Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study. Arch Intern Med (2010) 2.58

Social support and prognosis in patients at increased psychosocial risk recovering from myocardial infarction. Health Psychol (2007) 2.57

Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation (2014) 2.50

Obesity among those with mental disorders: a National Institute of Mental Health meeting report. Am J Prev Med (2009) 2.34

Relationship of depression to death or hospitalization in patients with heart failure. Arch Intern Med (2007) 2.33

Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics. PLoS One (2011) 2.30

Central nervous system injury associated with cardiac surgery. Lancet (2006) 2.27

Effects of exercise and stress management training on markers of cardiovascular risk in patients with ischemic heart disease: a randomized controlled trial. JAMA (2005) 2.18

Age moderates the short-term effects of transdermal 17beta-estradiol on endothelium-dependent vascular function in postmenopausal women. Arterioscler Thromb Vasc Biol (2007) 2.08

Effects of the dietary approaches to stop hypertension diet, exercise, and caloric restriction on neurocognition in overweight adults with high blood pressure. Hypertension (2010) 2.07

Intraoperative magnesium administration does not improve neurocognitive function after cardiac surgery. Stroke (2013) 2.05

Exercise and the treatment of clinical depression in adults: recent findings and future directions. Sports Med (2002) 2.02

Nighttime blood pressure dipping in postmenopausal women with coronary heart disease. Am J Hypertens (2012) 2.02

Statin-associated memory loss: analysis of 60 case reports and review of the literature. Pharmacotherapy (2003) 1.93

Cognitive function in late life depression: relationships to depression severity, cerebrovascular risk factors and processing speed. Biol Psychiatry (2006) 1.92

Usefulness of psychosocial treatment of mental stress-induced myocardial ischemia in men. Am J Cardiol (2002) 1.92

Social support and coronary heart disease: epidemiologic evidence and implications for treatment. Psychosom Med (2005) 1.88

Neuroimaging and early diagnosis of Alzheimer disease: a look to the future. Radiology (2003) 1.87

Phobic anxiety, depression, and risk of ventricular arrhythmias in patients with coronary heart disease. Psychosom Med (2006) 1.87

Systolic blood pressure, socioeconomic status, and biobehavioral risk factors in a nationally representative US young adult sample. Hypertension (2011) 1.80

Emotional antecedents of hot flashes during daily life. Psychosom Med (2005) 1.77

Cortical deactivation in mild cognitive impairment: high-field-strength functional MR imaging. Radiology (2007) 1.77

Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers. Radiology (2012) 1.74

Effects of perceived racism and anger inhibition on ambulatory blood pressure in African Americans. Psychosom Med (2003) 1.72

Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial. Arch Gen Psychiatry (2010) 1.72

Worsening depressive symptoms are associated with adverse clinical outcomes in patients with heart failure. J Am Coll Cardiol (2011) 1.71

Ethnic differences in the treatment of depression in patients with ischemic heart disease. Am Heart J (2008) 1.70

Low heart rate variability and the effect of depression on post-myocardial infarction mortality. Arch Intern Med (2005) 1.70

Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension. Haematologica (2008) 1.67

Effects of a telephone-based psychosocial intervention for patients awaiting lung transplantation. Chest (2002) 1.66

History of depression and survival after acute myocardial infarction. Psychosom Med (2009) 1.65

Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. Psychosom Med (2004) 1.64

Effects of spouse-assisted coping skills training and exercise training in patients with osteoarthritic knee pain: a randomized controlled study. Pain (2004) 1.63

Nighttime blood pressure dipping: the role of the sympathetic nervous system. Am J Hypertens (2002) 1.56

Associations among perceptions of social support, negative affect, and quality of sleep in caregivers and noncaregivers. Health Psychol (2006) 1.56

Spirituality, religion, and clinical outcomes in patients recovering from an acute myocardial infarction. Psychosom Med (2007) 1.56

Hostility, social support, and adrenergic receptor responsiveness among African-American and white men and women. Psychosom Med (2003) 1.55

Effects of coping skills training and sertraline in patients with non-cardiac chest pain: a randomized controlled study. Pain (2011) 1.55

Endothelial dysfunction: associations with exposure to ambient fine particles in diabetic individuals. Environ Health Perspect (2008) 1.53

Combination drug therapy for Alzheimer's disease: what is evidence-based, and what is not? Geriatrics (2005) 1.52

Association of neurocognitive function and quality of life 1 year after coronary artery bypass graft (CABG) surgery. Psychosom Med (2006) 1.51

Efficacy, safety, and tolerability of sertraline in patients with late-life depression and comorbid medical illness. J Am Geriatr Soc (2004) 1.49

Impaired endothelial function in coronary heart disease patients with depressive symptomatology. J Am Coll Cardiol (2005) 1.47

Amyloid deposition detected with florbetapir F 18 ((18)F-AV-45) is related to lower episodic memory performance in clinically normal older individuals. Neurobiol Aging (2012) 1.43

Serum creatinine patterns in coronary bypass surgery patients with and without postoperative cognitive dysfunction. Anesth Analg (2002) 1.41

Yoga on our minds: a systematic review of yoga for neuropsychiatric disorders. Front Psychiatry (2013) 1.40

Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease. Am J Psychiatry (2003) 1.40

Sex differences in the endothelial function of untreated hypertension. J Clin Hypertens (Greenwich) (2012) 1.39

Pain catastrophizing and pain-related fear in osteoarthritis patients: relationships to pain and disability. J Pain Symptom Manage (2008) 1.39